Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 21, 2014; 20(19): 5654-5659
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5654
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5654
Optimal treatment strategy for Helicobacter pylori: Era of antibiotic resistance
Jun Heo, Seong Woo Jeon, Department of Internal Medicine, Kyungpook National University Hospital Medical Center, Daegu 702-911, South Korea
Author contributions: Heo J and Jeon SW solely contributed to this paper.
Correspondence to: Seong Woo Jeon, MD, PhD, Department of Internal Medicine, Kyungpook National University Hospital Medical Center, 807, Hokuk-Ro, Book-Gu, Daegu 702-911, South Korea. sw-jeon@hanmail.net
Telephone: +82-53-2003517 Fax: +82-53-2002027
Received: September 27, 2013
Revised: November 29, 2013
Accepted: February 20, 2014
Published online: May 21, 2014
Processing time: 232 Days and 19.3 Hours
Revised: November 29, 2013
Accepted: February 20, 2014
Published online: May 21, 2014
Processing time: 232 Days and 19.3 Hours
Core Tip
Core tip: Currently, among the alternative first-line eradication regimens, concomitant and hybrid regimens have shown excellent results and could be the optimal treatment option. Levofloxacin-based quadruple therapy has shown promise as a rescue treatment.